权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Project 1: Tau metabolism: molecular chaperones, targeting and proteolysis

项目1：Tau代谢：分子伴侣、靶向和蛋白水解

基本信息

批准号：
10493227
负责人：
Aimee Kao
金额：
$ 46.41万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-09-27 至 2026-08-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10493227
关键词：
Address Affect Alzheimer&apos s Disease Amino Acid Sequence Animal Model Autophagocytosis Biology Cells Complex Coupling DNA Sequence Alteration Databases Degradation Pathway Disease Experimental Models Focus Groups Frontotemporal Dementia Frontotemporal Lobar Degenerations Gene Mutation Genetic Goals Half-Life Homeostasis Individual Induced pluripotent stem cell derived neurons Lead Lysosomes Maps Measures Metabolic Metabolic Pathway Metabolism Modeling Molecular Molecular Chaperones Mutation Nerve Degeneration Neurodegenerative Disorders Neuroglia Neurons Other Genetics Pathway interactions Peptide Hydrolases Phenotype Post-Translational Modification Site Post-Translational Protein Processing Prevention Proteolysis Regulation Research Personnel Resolution Resources Signal Transduction Site Structure System TSC1 gene Tauopathies Testing Variant Work base cell type genetic variant genomic locus improved insight multicatalytic endopeptidase complex polygenic risk score protein degradation protein metabolism protein protein interaction proteostasis tau Proteins tau aggregation tau interaction tau mutation tau phosphorylation

项目摘要

PROJECT SUMMARY: Project 1 Tau accumulates in primary neurodegenerative tauopathies such as frontotemporal dementia (FTD, also FTLD-tau) and secondary tauopathies such as Alzheimer’s Disease (AD). Mutations and variants in MAPT and other genetic loci promote this accumulation. By necessity, many groups focus on one aspect of the tau metabolic pathway, such as interactions with molecular chaperones or autophagic clearance, or a single mutation, such as P301L tau. These types of focused pursuits have generated many insights into tau biology but have not yet led to comprehensive understanding of tau metabolism, both normally and in disease. The \ goal of this center is to provide a comprehensive assessment of tau metabolism, inclusive of wild-type and mutant tau, as well as including effects of other genetic modifiers. Within the context of the proposed FTD Center without Walls, this project will address the more upstream aspects of tau metabolism and homeostasis: from tau interactions with molecular chaperones to achieving tau degradation. The long-term goal of this FTD Center without Walls (CWOW) is to fully understand the metabolism of tau and how it changes with disease mutations and variants. The overall objective of this project is to assess three nodes of tau metabolic regulation: 1) interactions with molecular chaperones and co-chaperones, 2) effects of post-translational modifica- tions (PTMs) on proteasomal and lysosomal targeting and 3) efficiency of tau proteolysis by individual lysosomal proteases. This project’s central hypothesis is that molecular chaperones, proteosomal and lysosomal targeting and lysosomal proteases are all potential nodes at which MAPT and other genetic mutations can contribute to the aberrant tau homeostasis found in neurodegenerative diseases. The rationale for this work is that through systematic study of how tau metabolism changes with gene variants and disease, one can better comprehend the molecular perturbations predisposing to tauopathy. Such understanding would provide a conceptual framework for understanding protein metabolism in the field of neurodegeneration and could lead to better strategies to improve tau clearance for treatment and/or prevention of FTLD-tau and AD. Aim 1: Generate a mechanistic understanding of the consequences of tau, molecular chaperone and co-chaperone interactions. Aim 2: Determine the functional effects of PTMs on tau targeting to the proteasome and autophagy/lysosome systems. Aim 3: Test the functional effects of tau pathway variants on lysosomal proteolysis of tau. Together with the other Project and Cores, this Project will assess upstream nodes in the tau metabolic pathway. It will contribute to functional phenotyping of gene variants and their effect on tau metabolism to aid in building the resources generated by the FTD CWOW, namely the Tau Metabolic Pathway Database (TMDB) and the Tau Polygenic Risk Score (TPRS).

项目概述：项目一